Canopy Growth posts smaller-than-expected core loss as costs drop
Aug 8 (Reuters) -Canadian pot firm Canopy Growth WEED.TO reported a smaller-than-expected core loss for the first quarter on Friday, helped by lower operating expenses and stronger demand for medical cannabis.
Its U.S.-listed shares CGC.O were up 3.3% at $7.15 in premarket trading.
Faced with increased competition in an overcrowded market, North American pot companies have been cutting costs and taking measures to reduce inventories to preserve cash and improve their finances.
Canopy Growth'squarterly operating expenses fell 23.7% to C$52.1 million ($37.92 million) from a year ago.
Revenue from its Canadian medical cannabis business rose 20.3% to C$18.8 million in the quarter ended June 30.
The company expects to achieve positive adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) on a consolidated basis in the second half of the fiscal year, CEO David Klein said.
Canopy Growth also pointed to easing doubts around the company's ability to continue as a going concern.
The company had raised doubts about its ability to continue as a going concern last year as it struggled to turn profitable. It later sold its sports nutrition products unit, Biosteel, after seeking bankruptcy protection for it.
The company reported a first-quarter adjusted core loss of C$5.3 million, compared with analysts' average estimate of C$7.1 million, according to LSEG data.
Peer Aurora Cannabis ACB.TO reported strong quarterly results earlier this week, helped by growth in medical cannabis segment.
($1 = 1.3739 Canadian dollars)
Reporting by Tanay Dhumal in Bengaluru; Editing by Shreya Biswas
免责声明: XM Group仅提供在线交易平台的执行服务和访问权限，并允许个人查看和/或使用网站或网站所提供的内容，但无意进行任何更改或扩展，也不会更改或扩展其服务和访问权限。所有访问和使用权限，将受下列条款与条例约束：(i) 条款与条例；(ii) 风险提示；以及(iii) 完整免责声明。请注意，网站所提供的所有讯息，仅限一般资讯用途。此外，XM所有在线交易平台的内容并不构成，也不能被用于任何未经授权的金融市场交易邀约和/或邀请。金融市场交易对于您的投资资本含有重大风险。
所有在线交易平台所发布的资料，仅适用于教育/资讯类用途，不包含也不应被视为用于金融、投资税或交易相关咨询和建议，或是交易价格纪录，或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。
本网站上由XM和第三方供应商所提供的所有内容，包括意见、新闻、研究、分析、价格、其他资讯和第三方网站链接，皆保持不变，并作为一般市场评论所提供，而非投资性建议。所有在线交易平台所发布的资料，仅适用于教育/资讯类用途，不包含也不应被视为适用于金融、投资税或交易相关咨询和建议，或是交易价格纪录，或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。请确保您已阅读并完全理解，XM非独立投资研究提示和风险提示相关资讯，更多详情请点击 这里。
